Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma, B-Cell × selinexor × Clear all

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 10 Leukemia, Myeloid, Acute 10 Recurrence 8 Lymphoma, Large B-Cell, Diffuse 4 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Endometrial Neoplasms 2 Congenital Abnormalities 2 Colorectal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Solid Tumors 1 Sarcoma, Endometrial Stromal 1 Salivary Gland Neoplasms 1 Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1

Interventions

Rituximab 39 Cyclophosphamide 20 ibrutinib 11 fludarabine 9 Doxorubicin 9 Vincristine 8 pembrolizumab 7 Prednisone 7 Etoposide 7 Cytarabine 7 fludarabine phosphate 6 Inotuzumab Ozogamicin 6 Bortezomib 6 obinutuzumab 5 tositumomab I-131 4 Prednisolone 4 Mycophenolic Acid 4 Lenalidomide 4 tocilizumab 3 tazemetostat 3 Tacrolimus 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Oxaliplatin 3 Methotrexate 3 Melphalan 3 Gemcitabine 3 Clofarabine 3 Carmustine 3 Brentuximab Vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02741388 2021-12-07

SELINDA

The Lymphoma Academic Research Organisation

Phase 1 Completed

Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡